Skip to main content
. 2013 May 27;9(3):427–433. doi: 10.5114/aoms.2013.35324

Table II.

Therapeutic approach

Variable Females n = 65 (%) Males n = 462 (%) Value of p
Medical therapy 15 (23.1) 135 (29.2) 0.30
Coronary angiography 48 (73.9) 305 (66.0) 0.21
Anti-GP IIb/IIIa 15 (23.1) 94 (20.3) 0.81
Thrombolysis 4 (6.2) 28 (6.1) 0.77
PCI 40 (61.5) 242 (52.4) 0.17

GP – glycoprotein, PCI – percutaneous coronary intervention